{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:35:52Z","timestamp":1770964552632,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1993,6,1]],"date-time":"1993-06-01T00:00:00Z","timestamp":738892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1993,6]]},"DOI":"10.1007\/bf01295732","type":"journal-article","created":{"date-parts":[[2005,3,25]],"date-time":"2005-03-25T06:58:23Z","timestamp":1111733903000},"page":"1132-1136","source":"Crossref","is-referenced-by-count":26,"title":["Prospective, randomized, investigator-blind trial ofHelicobacter pylori infection treatment in patients with refractory duodenal ulcers"],"prefix":"10.1007","volume":"38","author":[{"given":"Gerassimos J.","family":"Mantzaris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanassios","family":"Hatzis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Tamvakologos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalliopi","family":"Petraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charis","family":"Spiliades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Triadaphyllou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1136\/gut.28.9.1120","volume":"28","author":"DB Jones","year":"1987","unstructured":"Jones DB, Howden CW, Burget DW, Keer GD, Hunt RH: Acid suppression in duodenal ulcer: A meta-analysis to define optional dosing with antisecretory drugs. Gut 28:1120?1127, 1987","journal-title":"Gut"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1136\/bmj.293.6560.1501","volume":"293","author":"KG Wormsley","year":"1986","unstructured":"Wormsley KG: Relapse of duodenal ulcer. Br Med J 293:1502, 1986","journal-title":"Br Med J"},{"key":"CR3","first-page":"14","volume-title":"Ranitidine: Therapeutic advances","author":"EJS Boyd","year":"1984","unstructured":"Boyd EJS, Wilson JA, Wormsley KG: Recurrent ulcer disease.In Ranitidine: Therapeutic advances. JJ Misiewicz, JR Wood (eds). Amsterdam, Excepta Medica, 1984, pp 14?42"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(81)90114-8","volume":"1","author":"D Martin","year":"1981","unstructured":"Martin D, May S, Tweedle D, Hollanders D, Ravenscroft M, Miller J: Differences in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitratobismuthate. Lancet 1:7?10, 1981","journal-title":"Lancet"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(88)91961-7","volume":"1","author":"MR Lane","year":"1988","unstructured":"Lane MR, Lee SP: Recurrence of duodenal ulcer after medical treatment. Lancet 1:1147?1149, 1988","journal-title":"Lancet"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0016-5085(89)80059-9","volume":"96","author":"SG Chiverton","year":"1989","unstructured":"Chiverton SG, Hunt RH: Initial therapy and relapse of duodenal ulcer: Possible and secretory mechanisms. Gastroenterology 96:632?639, 1989","journal-title":"Gastroenterology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/bmj.293.6548.645","volume":"293","author":"CAM McNaulty","year":"1986","unstructured":"McNaulty CAM, Gearty JC, Crump B, Davis M, Donovan IA, Melekian V, Lister DM, Wise R:Campylobacter pyloridis and associated gastritis: Investigator-blind placebo-controlled trial of bismuth salicylate and erythromycine ethylsuccinate. Br Med J 293:645?649, 1986","journal-title":"Br Med J"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0016-5085(88)90606-3","volume":"94","author":"EAJ Rauws","year":"1988","unstructured":"Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GNJ:Campylobacter pyloridis-associated chronic active antral gastritis: A prospective study of its prevalence and the effects of anti-bacterial and anti-ulcer treatment. Gastroenterology 94:33?40, 1988","journal-title":"Gastroenterology"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1128\/AAC.28.6.837","volume":"28","author":"CA McNulty","year":"1985","unstructured":"McNulty CA, Dent J, Wise R: Susceptibility of clinical isolates ofCampylobacter pylori to 11 anti-microbial agents. Antimicrob Agents Chemother 28:837?838, 1985","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl","key":"CR10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000199553","volume":"37","author":"SJ Konturek","year":"1987","unstructured":"Konturek SJ, Radecki T, Piastucki I, Drozdowicz D: Studies on the gastroprodective and ulcer-healing effects of colloidal bismuth subcitrate. Digestion 37(suppl):8?15, 1987","journal-title":"Digestion"},{"issue":"suppl 157","key":"CR11","first-page":"3","volume":"24","author":"DWR Hall","year":"1988","unstructured":"Hall DWR: Review of the modes of action of colloidal bismuth subcitrate. Scand J Gastroenterol 24(suppl 157):3?6, 1988","journal-title":"Scand J Gastroenterol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2036.1989.tb00187.x","volume":"3","author":"CJ Gavey","year":"1989","unstructured":"Gavey CJ, Szeto M-L, Nwokolo CU, Sercombe J, Pounder RE: Bismuth accumulates in the body during treatment with tripotassium dicitratobismuthate. Aliment Pharmacol Ther 3:21?28, 1989","journal-title":"Aliment Pharmacol Ther"},{"key":"CR13","first-page":"1273","volume":"1","author":"BJ Marshall","year":"1983","unstructured":"Marshall BJ: Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1:1273?1275, 1983","journal-title":"Lancet"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","volume":"1","author":"BJ Marshall","year":"1984","unstructured":"Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of the patients with gastritis and peptic ulceration. Lancet 1:1311?1315, 1984","journal-title":"Lancet"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(87)91545-5","volume":"2","author":"JG Coghlan","year":"1987","unstructured":"Coghlan JG, Gilligan D, Humphries H, McKenna D, Dooley C, Sweeney E, Keane C, O'Morain C:Campylobacter pylori and recurrence of duodenal ulcers-a 12 month follow-up study. Lancet 2:1109?1111, 1987","journal-title":"Lancet"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/jcp.40.8.841","volume":"40","author":"JI Wyatt","year":"1987","unstructured":"Wyatt JI, Rathbone GJ, Dixon MF, Heatly RV:Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol 40:841?848, 1987","journal-title":"J Clin Pathol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(88)90929-4","volume":"2","author":"BJ Marshall","year":"1988","unstructured":"Marshall BJ, Warren JR, Blincow ED, Philips M, Goodwin CS, Murray R, Blackbourn SJ, Waters TE, Sanderson CR: Prospective double blind trial of duodenal ulcer relapse after eradication ofCampylobacter pylori. Lancet 2:1437?1442, 1988","journal-title":"Lancet"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/gut.33.3.289","volume":"33","author":"S Moss","year":"1992","unstructured":"Moss S, Calam J:Helicobacter pylori and peptic ulcers: The present position. Gut 33:289?292, 1992","journal-title":"Gut"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/0140-6736(90)91301-P","volume":"335","author":"EAJ Rauws","year":"1990","unstructured":"Rauws EAJ, Tytgat GNJ: Cure of duodenal ulcer associated with eradication ofHelicobacter pylori. Lancet 335:1233?1235, 1990","journal-title":"Lancet"},{"key":"CR20","first-page":"43","volume":"94","author":"TJ Borody","year":"1988","unstructured":"Borody TJ, Cole P, Noonan S, Morgan A, Ossip G, Maysay J, Brandl S: Long termCampylobacter pylori recurrence post eradication. Gastroenterology 94:43, 1988 (abstract)","journal-title":"Gastroenterology"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1365-2036.1990.tb00513.x","volume":"4","author":"J Weil","year":"1990","unstructured":"Weil J, Bell GD, Powell K, Morden A, Harrison G, Gant PW, Jones PH, Trowell JE:Helicobacter pylori infection treatment with a tripotassium dicitratobismuthate and metronidazole combination. Aliment Pharmacol Ther 4:651?658, 1990","journal-title":"Aliment Pharmacol Ther"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1136\/gut.29.10.1386","volume":"29","author":"T Rokkas","year":"1988","unstructured":"Rokkas T, Pursey C, Uzechina E, Dorrington L, Simmons NA, Filipe MI, Sladen GE: Non-ulcer dyspepsia and short term DeNol therapy: A placebo controlled trial with particular reference to the role ofCampylobacter pylori. Gut 29:1386?1391, 1988","journal-title":"Gut"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jcp.25.1.1","volume":"25","author":"R Whitehead","year":"1972","unstructured":"Whitehead R, Truelove SC, Gear MWL: The histological diagnosis of chronic gastritis in fiberoptic gastroscope biopsy specimens. J Clin Pathol 25:1?11, 1972","journal-title":"J Clin Pathol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2036.1990.tb00503.x","volume":"4","author":"JG Penston","year":"1990","unstructured":"Penston JG, Wormsley KG: Review article: Asymptomatic duodenal ulcers?implications of heterogeneity. Aliment Pharmacol Ther 4:557?568, 1990","journal-title":"Aliment Pharmacol Ther"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-116-9-705","volume":"116","author":"DY Graham","year":"1992","unstructured":"Graham DY, Lew GM, Klein PD, et al.: Effect of treatment ofHelicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. Ann Intern Med 116:705?708, 1992","journal-title":"Ann Intern Med"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/gut.33.2.179","volume":"33","author":"S Wagner","year":"1992","unstructured":"Wagner S, Gebel M, Haruma K, et al.: Bismuth subsalicylate in the treatment of H2 blocker resistant duodenal ulcers: Role ofHelicobacter pylori. Gut 33:179?183, 1992","journal-title":"Gut"},{"key":"CR27","first-page":"1032","volume":"83","author":"KD Dye","year":"1992","unstructured":"Dye KD, Marshall BJ, Frierson HF, Barrett LJ, McCallum RW: Is CLOtest alone adequate to diagnoseCampylobacter pylori? Am J Gastroenterol 83:1032, 1992 (abstract)","journal-title":"Am J Gastroenterol"},{"key":"CR28","first-page":"A410","volume":"94","author":"GA Schnell","year":"1988","unstructured":"Schnell GA, Schubert TT, Barnes WG, Rupani MK: Comparison of urease, H&E, and culture tests forCampylobacter pylori. Gastroenterology 94:A410, 1988","journal-title":"Gastroenterology"},{"issue":"Suppl 160","key":"CR29","first-page":"19","volume":"24","author":"M Delterne","year":"1989","unstructured":"Delterne M, Glupczynski Y, DePrez C, et al: The reliability of urease test, histology and culture in the diagnosis ofCampylobacter pylori infections. Scand J Gastroenterol 24(Suppl 160):19?24, 1989","journal-title":"Scand J Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01295732.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01295732\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01295732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T11:26:04Z","timestamp":1556796364000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01295732"}},"subtitle":["Healing and long-term relapse rates"],"short-title":[],"issued":{"date-parts":[[1993,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1993,6]]}},"alternative-id":["BF01295732"],"URL":"https:\/\/doi.org\/10.1007\/bf01295732","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,6]]}}}